The Goldman Sachs Group, Inc. 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-06 2:29 pm Purchase |
2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR |
GOLDMAN SACHS GROUP INC GS |
4,492,017 7.000% |
4,492,017 (New Position) |
Filing |